Mathias Gebauer

Summary

Affiliation: Aventis Pharma

Publications

  1. ncbi Microarray applications: emerging technologies and perspectives
    Mathias Gebauer
    Functional Genomics Department, Aventis Pharma, Industriepark Hoechst, 65926 Frankfurt am Main, Germany
    Drug Discov Today 9:915-7. 2004
  2. ncbi Repression of anti-proliferative factor Tob1 in osteoarthritic cartilage
    Mathias Gebauer
    Aventis Pharma Deutschland, Functional Genomics, Sanofi Aventis, Frankfurt, Germany
    Arthritis Res Ther 7:R274-84. 2005
  3. ncbi Functional profiling of human atrial and ventricular gene expression
    Andreas S Barth
    Department of Medicine I, University Hospital Grosshadern, Ludwig Maximilians University, Marchioninistrasse 15, 81377, Munich, Germany
    Pflugers Arch 450:201-8. 2005
  4. ncbi Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure
    Stefan Kaab
    Medizinische Klinik und Poliklinik I, Klinikum der Universitat Munchen, Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany
    J Mol Med (Berl) 82:308-16. 2004
  5. ncbi Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature
    Andreas S Barth
    Department of Medicine I, University Hospital Grosshadern, Munich, Germany
    Circ Res 96:1022-9. 2005

Collaborators

  • Masaharu Takigawa
  • Stefan Kaab
  • Sylvia Merk
  • T Aigner
  • Andreas S Barth
  • Gerhard Steinbeck
  • Ludwig Zwermann
  • Martin Dugas
  • Klaus Steinmeyer
  • Michael Nabauer
  • Markus Bleich
  • Patrick Kloos
  • Elisabeth Arnoldi
  • Martin Hinterseer
  • Peter Uberfuhr
  • Heike Kartmann
  • Eckart Kreuzer
  • Arne Pfeufer

Detail Information

Publications5

  1. ncbi Microarray applications: emerging technologies and perspectives
    Mathias Gebauer
    Functional Genomics Department, Aventis Pharma, Industriepark Hoechst, 65926 Frankfurt am Main, Germany
    Drug Discov Today 9:915-7. 2004
    ..Topics addressed at the meeting included the uses of padlock probes and nanomechanical cantilevers and microarray applications for patient profiling...
  2. ncbi Repression of anti-proliferative factor Tob1 in osteoarthritic cartilage
    Mathias Gebauer
    Aventis Pharma Deutschland, Functional Genomics, Sanofi Aventis, Frankfurt, Germany
    Arthritis Res Ther 7:R274-84. 2005
    ..Activation, the reinitiation of proliferative activity and the loss of a stable phenotype are three major changes in osteoarthritic chondrocytes that are highly significantly correlated with the repression of Tob1 expression...
  3. ncbi Functional profiling of human atrial and ventricular gene expression
    Andreas S Barth
    Department of Medicine I, University Hospital Grosshadern, Ludwig Maximilians University, Marchioninistrasse 15, 81377, Munich, Germany
    Pflugers Arch 450:201-8. 2005
    ..Moreover, as major functional classes of atrial- and ventricular-specific transcripts were common to human and murine myocardium, an evolutionarily conserved chamber-specific expression pattern in mammalian myocardium is suggested...
  4. ncbi Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure
    Stefan Kaab
    Medizinische Klinik und Poliklinik I, Klinikum der Universitat Munchen, Grosshadern, Marchioninistrasse 15, 81377 Munich, Germany
    J Mol Med (Berl) 82:308-16. 2004
    ..Recognizing common gene expression patterns in heart failure will significantly contribute to the understanding of heart failure and may eventually lead to the development of pathway-specific therapies...
  5. ncbi Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature
    Andreas S Barth
    Department of Medicine I, University Hospital Grosshadern, Munich, Germany
    Circ Res 96:1022-9. 2005
    ..Therefore, dedifferentiation with adoption of a ventricular-like signature is a general feature of the fibrillating atrium...